Severe Raynaud's phenomenon associated with interferon-beta therapy for multiple sclerosis: case report

被引：9

作者：

Cruz, BA

De Queiroz, E

Nunes, SV

Cruz, A

Campos, GB

Monteiro, ELD

Crivellari, H

机构：

[1] Hosp Governador Israel Pinheiro, Serv Neurol, Belo Horizonte, MG, Brazil

[2] Hosp Governador Israel Pinheiro, Med Clin, Belo Horizonte, MG, Brazil

[3] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil

来源：

ARQUIVOS DE NEURO-PSIQUIATRIA | 2000年 / 58卷 / 2B期

关键词：

multiple sclerosis; interferon-beta; Raynaud's phenomenon;

D O I：

10.1590/S0004-282X2000000300025

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Interferon-beta (IFN-beta) is administered for treatment of multiple sclerosis (MS). We report on a woman with MS who presented with severe Raynaud's phenomenon, livedo-reticularis and digital necrosis two weeks after beginning therapy with IFN-beta. symptoms improved after the IFN-beta was discontinued and anticoagulation associated with cyclophosphamide and corticoid were introduced. Raynaud's phenomenon is probably a side effect of IFN-beta therapy for multiple sclerosis.

引用

页码：556 / 559

页数：4

共 19 条

[1]

Alsalameh S, 1998, ARTHRITIS RHEUM, V41, P754, DOI 10.1002/1529-0131(199804)41:4<754::AID-ART33>3.0.CO

[2]

2-K

[3] Raynaud's phenomenon and digital necrosis induced by interferon-alpha [J].

Bachmeyer, C ;

Farge, D ;

Gluckman, E ;

Miclea, JM ;

Aractingi, S .

BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (03) :481-483

[4]

CONLON KC, 1990, CANCER, V65, P2237, DOI 10.1002/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO

[5]

2-5

[6]

DUQUETTE P, 1995, NEUROLOGY, V45, P1277

[7]

DURUM SK, 1993, FUNDAMENTAL IMMUNOLO, P815

[8] INTERFERON-ASSOCIATED RETINOPATHY [J].

GUYER, DR ;

TIEDEMAN, J ;

YANNUZZI, LA ;

SLAKTER, JS ;

PARKE, D ;

KELLEY, J ;

TANG, RA ;

MARMOR, M ;

ABRAMS, G ;

MILLER, JW ;

GRAGOUDAS, ES .

ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (03) :350-356

[9] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].

Jacobs, LD ;

Cookfair, DL ;

Rudick, RA ;

Herndon, RM ;

Richert, JR ;

Salazar, AM ;

Fischer, JS ;

Goodkin, DE ;

Granger, CV ;

Simon, JH ;

Alam, JJ ;

Bartoszak, DM ;

Bourdette, DN ;

Braiman, J ;

Brownscheidle, CM ;

Coats, ME ;

Cohan, SL ;

Dougherty, DS ;

Kinkel, RP ;

Mass, MK ;

Munschauer, FE ;

Priore, RL ;

Pullicino, PM ;

Scherokman, BJ ;

WeinstockGuttman, B ;

Whitman, RH ;

Baird, WC ;

Fillmore, M ;

Bona, LM ;

ColonRuiz, ME ;

Nadine, BS ;

Donovan, A ;

Bennett, S ;

Kieffer, YM ;

Umhauer, MA ;

Miller, CE ;

Kilic, AK ;

Sargent, EL ;

Schachter, M ;

Shucard, DW ;

Weider, V ;

Catalano, BA ;

Cervi, JM ;

Czekay, C ;

Farrell, JL ;

Filippini, JS ;

Matyas, RC ;

Michienzi, KE ;

Ito, M ;

OMalley, JA .

ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294

[10]

Levesque MC, 1999, ARTHRITIS RHEUM, V42, P569, DOI 10.1002/1529-0131(199904)42:3<569::AID-ANR23>3.0.CO

← 1 2 →